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Arc is a unique immediate early gene (IEG) whose expression is induced as synapses are
modified during learning. Newly-synthesized ArcmRNA is rapidly transported throughout
dendrites and localizes near recently activated synapses. ArcmRNA levels are regulated
by rapid degradation, which is accelerated by synaptic activity in a translation-dependent
process. One possible mechanism is nonsense-mediated mRNA decay (NMD), which
depends on the presence of a splice junction in the 3′UTR. Here, we test this hypothesis
using transgenic mice that express EGFP-Arc. Because the transgene was constructed
from Arc cDNA, it lacks intron structures in the 3′UTR that are present in the endogenous
Arc gene. NMD depends on the presence of proteins of the exon junction complex
(EJC) downstream of a stop codon, so EGFP-Arc mRNA should not undergo NMD.
Assessment of Arc mRNA rundown in the presence of the transcription inhibitor
actinomycin-D confirmed delayed degradation of EGFP-Arc mRNA. EGFP-Arc mRNA
and protein are expressed at much higher levels in transgenic mice under basal and
activated conditions but EGFP-Arc mRNA does not enter dendrites efficiently. In a
physiological assay in which cycloheximide (CHX) was infused after induction of Arc
by seizures, there were increases in endogenous Arc mRNA levels consistent with
translation-dependent Arc mRNA decay but this was not seen with EGFP-Arc mRNA.
Taken together, our results indicate: (1) Arc mRNA degradation occurs via a mechanism
with characteristics of NMD; (2) rapid dendritic delivery of newly synthesized Arc mRNA
after induction may depend in part on prior splicing of the 3′UTR.
Keywords: LTP, synaptic plasticity, protein synthesis, dendrite, dendritic mRNA, dendritic spines, immediate early
gene, nonsense-mediated decay
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SIGNIFICANCE
Studies of the immediate early gene Arc have revealed
fundamental cell biological mechanisms of mRNA transport into
dendrites and localization at active synapses and mechanisms
of Arc mRNA transcription and degradation. Here, we show
that two key aspects of Arc mRNA dynamics are dependent
on introns in the 3′UTR of Arc mRNA. In transgenic mice
expressing an EGFP-Arc transgene with the Arc-EGFP coding
regions and Arc 3′UTR that lacks introns, degradation of EGFP-
Arc mRNA is delayed and dendritic transport is impaired in
comparison to endogenous Arc mRNA. Our findings elucidate
features of Arc mRNA turnover and dendritic transport and
highlight the usefulness of EGFP-Arc transgenic mice for studies
of the functional significance of Arc expression dynamics and
dendritic transport.
INTRODUCTION
The immediate early gene Arc (Lyford et al., 1995), also known
as Arg 3.1 (Link et al., 1995), has been implicated in synaptic
modifications that underlie memory storage (Steward et al.,
2014). Arc transcription is induced by learning experiences or
strong synaptic activity, and Arc is unique amongst IEGs in that
newly-synthesized Arc mRNA is rapidly transported throughout
dendrites (Link et al., 1995; Lyford et al., 1995). If synapses
are strongly activated as Arc mRNA moves into dendrites, Arc
mRNA localizes selectively near the active synapses (Steward
et al., 1998). Patterns of synaptic activation that induce Arc
transcription simultaneously trigger Arc mRNA degradation
(Farris et al., 2014). Indeed, it is a combination of selective
docking of newly-synthesized Arc mRNA near active synapses
and activity-dependent Arc mRNA degradation that sharpens
the selectivity of Arc localization in activated dendritic domains
(Farris et al., 2014).
An important, but poorly-understood aspect of Arc is
its expression dynamics. Rapid activity-dependent induction
is consistent with Arc’s putative role in synaptic plasticity.
Arc protein is subject to ubiquitination and proteosomal
degradation (Mabb et al., 2014), but mechanisms underlying
rapid degradation of Arc mRNA are not worked out. A possible
mechanism for Arc mRNA decay is nonsense-mediated mRNA
decay (NMD), which is triggered when a translating ribosome
reaches the stop codon and interacts with the exon junction
complex (EJC) at a downstream splice site (Giorgi et al., 2007).
The Arc gene consists of a single open-reading frame exon
and two introns in its 3′UTR. After pre-mRNA processing, EJC
proteins remain bound to Arc mRNA as it moves into the
cytoplasm, and the presence of a splice site with EJC’s more
than about 70 nt downstream of a stop codon is the canonical
signal for NMD. It is not clear, however, whether activity-driven
degradation of ArcmRNA occurs via this mechanism.
A pivotal test of the hypothesis is to determine if Arc
transcripts that were never spliced (and thus do not have
associated EJC proteins) are degraded in the same way as
endogenous Arc mRNA. To test this, the present study uses
a line of transgenic mice in which an EGFP-Arc fusion gene
that includes the 3′ and 5′UTRs of Arc is expressed under the
control of the 7kb Arc promoter, which recapitulates the activity-
dependent expression of Arc (Kawashima et al., 2009; Okuno
et al., 2012). Importantly, the transgene was created from Arc
cDNA, which lacks any introns, thus, the transcript is not spliced.
If Arc mRNA is degraded by NMD, then: (1) Endogenous
Arc mRNA should be degraded more quickly than EGFP-Arc
mRNA; (2) Inhibition of protein synthesis should lead to
increases in endogenous Arc mRNA (Farris et al., 2014), but not
EGFP-Arc mRNA levels; and (3) EGFP-Arc mRNA should not
undergo activity-dependent degradation. Consistent with these
predictions, we show here that EGFP-Arc mRNA transcription
is induced by the same stimuli that induce endogenous Arc
expression but EGFP-Arc mRNA has a longer half-life than
endogenous ArcmRNA. Unexpectedly, we found that EGFP-Arc
mRNA was not delivered into dendrites to the same degree
as endogenous Arc mRNA after induction, suggesting that
rapid dendritic delivery of newly synthesized Arc mRNA may
depend on or be facilitated by prior splicing of the 3′UTR.
Although experiments to assess translation-dependence of Arc
mRNA decay were complicated by the fact that consequences
of inhibiting protein synthesis were less striking in mice
than previously seen in rats, overall results supported the
conclusion that unlike endogenous Arc mRNA, EGFP-Arc
mRNA degradation is not accelerated by mRNA translation. We
also found that EGFP-Arc protein also is not degraded with the
rapid kinetics of endogenous Arc protein resulting in higher
levels of total Arc protein in EGFP-Arc-transgenic mice than in
wildtype controls.
METHODS
Experimental Animals
Most experiments were carried out using adult male and female
mice from our breeding colony that was established using
founders derived from frozen embryos of EGFP-Arc mice from
Okuno and Bito (Okuno et al., 2012). Founder mice were crossed
with C57Bl/6 mice to expand the colony and hemizygous mice
were then set up in breeding pairs to obtain hemizygous and
homozygous transgenic EGFP-Arc mice, and controls with only
wild type (WT) Arc. Some of the neurophysiology experiments
used C57Bl/6/J mice obtained from Jackson Labs as detailed
in the Results. All procedures involving live animals were
approved by the Institutional Animal Care and Use Committees
of the University of California Irvine, Kyoto University, and the
University of Tokyo.
Mice were genotyped by a commercial vendor (Transnetyx)
by TaqMan R© qPCRwith forward primer: CGTCGTCCTTGAAG
AAGATGGT, Reverse Primer: CACATGAAGCAGCACGACTT
and an internal oligo with a fluorescent probe (CATGCCCGAA
GGCTAC). As noted in the Results, we also found that genotype
could be easily determined by in situ hybridization.
Novel Enriched Environment
To assess Arc induction due to a brief learning experience,
mice were allowed to explore a novel toy-filled environment for
1 h, which we previously referred to as “unsupervised learning”
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(Farris et al., 2014). The environment was a 24 × 24 in square
plexiglass box with various small items that mice could climb,
crawl under, or that moved when touched.
To test whether Arc and EGFP-Arc mRNA levels depended
on ongoing translation as predicted by NMD-dependent mRNA
degradation, we tested whether inhibition of protein synthesis
with cycloheximide (CHX; 20 mg/kg i.p.) led to increases in
mRNA levels as previously reported in rats (Farris et al., 2014). To
assess effects of CHX onArcmRNA levels under basal conditions,
mice were gently removed from their home cage, received CHX
or saline and were returned to their home cage for 1 h. To
assess whether CHX led to increased mRNA levels following a
learning experience, pairs of mice were allowed to explore the
novel environment for 1 h. Onemouse in each pair received CHX
(20 mg/kg i.p.); the other received saline. Brains from mice that
received CHX or saline were mounted together on microscope
slides and hybridized or immunostained in the same solutions.
This strategy allowed direct comparisons of mRNA and protein
levels in brains from mice of the same genotype and with very
similar experience with and without CHX.
Electroconvulsive Seizures
A single electroconvulsive seizure (ECS) was induced as
described previously (Wallace et al., 1998). Current was passed
transcranially (10mA for 0.5 s) via ear clip electrodes resulting in
a generalized tonic/clonic seizure that lasted approximately 15 s.
Neurophysiology
Mice were anesthetized via intraperitoneal injections of 20%
urethane (500 mg/kg body weight) with supplemental doses
given approximately every 10min until the animal was
unresponsive to tail pinch. Mice were positioned in a stereotaxic
apparatus and burr holes were placed in the skull to allow
placement of stimulating and recording electrodes. An insulated
monopolar stimulating electrode was positioned stereotaxically
at 3.0mm lateral to the midline at the transverse sinus. The
depth of the stimulating electrode was adjusted so as to optimally
activate the medial perforant path (MPP) originating from the
medial entorhinal cortex (EC)—usually about 3mm below the
cortical surface. Glass recording electrodes filled with 0.9% saline
were positioned at 1.5–1.8mm lateral to the midline, and 2.0mm
posterior to bregma. Electrodes were positioned in the dorsal
blade of the dentate gyrus so as to record field potentials from
the cell body layer.
Stimulation Paradigm
After positioning the stimulating and recording electrodes,
stimulus intensity was set so as to evoke a population spike of
3–6mV. Single test pulses were delivered at a rate of 1/10 s at the
same intensity for 10min in order to determine baseline response
amplitude; measures were the slope of the population EPSP and
amplitude of the population spike. Following baseline recordings,
3 rounds of high frequency stimulation was delivered, with each
round consisting of ten trains of eight pulses at 400Hz and each
train given at a rate of 1/10 s. After each bout of HFS, a round of
ten test pulses was given to determine the extent of LTP. Then,
HFS was continued at a rate of one 400 hz train per 10 s for 1 h.
Assessment of mRNA Half-Life in Vivo
To assess the half-life of EGFP-Arc mRNA vs. endogenous
Arc mRNA in vivo, we assessed rundown of mRNA levels
after transcriptional block with actinomycin-D (Act-D). Arc
transcription was induced in transgenic and WT mice by
delivering an electroconvulsive seizure (ECS) and time was
allowed for mRNA levels to ramp up. Mice received injections
of anesthetic (urethane) about 45min post-ECS and were placed
in a stereotaxic device. A recording micropipette containing 2
mg/ml Act-D mannitol in saline was stereotaxically positioned
in the dentate gyrus at approximately 1 h post-ECS and a
monopolar stimulating electrode was placed in the entorhinal
cortex as above. The final position of the Act-D-containing
micropipette was adjusted by monitoring evoked responses
generated by stimulation of the entorhinal cortex. Micropipettes
containing Act-Dwere left in place for 30 or 60min (3–4mice per
group at each time point except for 30minWTwhere n= 2), after
which brains were harvested for fluorescent in situ hybridization
(FISH).
Tissue Preparation
Mice were killed by a lethal injection of the anesthetic Euthasol
or Fatal Plus R© depending on the IACUC protocol in effect on
the date of the experiment. Un-fixed brains were removed and
rapidly frozen. For chromogen-based in situ hybridization, mice
were perfused with 4% paraformaldehyde in phosphate buffered
saline (PBS, pH 7.4). Brains were cryoprotected by placing in 25%
sucrose overnight and sectioned at 20µmon a cryostat and slides
with sections were stored at−80◦C until use.
In Situ Hybridization
The cRNA probe for Arc/Arg3.1 was generated as described
previously (Steward et al., 1998). The EGFP gene from EGFP-N1
was cloned into the BamHI-NotI site of Bluescript KS(+). For
transcribing cRNA probes, the Bluescript vector was linearized
with BamHI.
Fluorescent in situ hybridization (FISH) was performed on
20µm coronal sections prepared from flash-frozen brains as
described by Guzowski et al. (1999). cRNA riboprobes were
generated using the Ambion MaxiScript kit and a premixed
RNA labeling nucleotide mix containing digoxigenin-labeled
UTP (Roche Molecular Biochemicals). Sections were incubated
with the digoxigenin-labeledArc antisense riboprobe (1–2 ng/ml)
for 16–20 h. Subsequent to washes of various stringencies, slides
were incubated with a horseradish peroxidase (HRP)-conjugated
antibody to digoxigenin. HRP was detected using the Tyramide
Signal Amplification fluorescence (TSA-CY3) kit from Perkin
Elmer or from tyramide-FITC synthesized in lab as described
(Hopman et al., 1998). In some experiments, sections were also
stained with DAPI to mark nuclei. Slides were coverslipped
using Vectashield R© mounting medium (Vector Laboratories).
Comparisons of patterns of labeling and quantitative analyses
were done using slides that were hybridized or immunostained
in the same run to control for variability in the extent of
hybridization/immunostaining.
For chromagen-based in situ hybridization slide-mounted
sections were post-fixed with 4% paraformaldehyde in 0.1M
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PBS for 30min, then rinsed with 0.5x saline-sodium citrate
buffer (0.5xSSC, 0.1%DEPC treated) for 5min. Sections were
treated with Proteinase K (1.25 mg/L) for 30min, rinsed again
with 0.5xSSC (0.1%DEPC treated) for 10min and air-dried. The
sections were covered with 75 µl prehybridization buffer (2xSSC,
25% formamide, 1% Denhardt’s reagent, 10% dextran sulfate,
0.5 mg/mL heparin, 0.5 mg/ml yeast tRNA and 0.25 mg/mL of
denatured salmon sperm DNA) and incubated at 42◦C for 2 h.
After the prehybridization, about 0.5µg of Dig-cRNA probe in 75
µl hybridization buffer was added to each section. The sections
were covered with a baked coverslip, and incubated overnight
at 55◦C in a humidified box with 25% formamide/2xSSC. The
next day, the coverslips were removed and sections were washed
with 2xSSC/10mM EDTA twice (10min each). The sections
were treated with RNAse-A for 30min, and then washed twice
with 2xSSC/EDTA (10min per wash). The stringency wash was
0.5xSSC/10 mMEDTA at 55◦C for 2 h. Sections were washed
with 0.5xSSC twice (10min each at room temperature). Alkaline
phosphatase conjugated anti-digoxigenin Fab fragment (1:5,000)
was used to detect the probes. NBT/BCIP solution was applied
overnight at 4◦C to detect the alkaline phosphatase. Sections were
washed with 100mM Tris-HCl (pH 8.5)/1mM EDTA 3 times,
10min each. Then slides were briefly rinsed with nanopure water
twice and covered with Kaiser’s glycerol jelly.
Quantification of FISH
Quantification of FISH was done using NIH ImageJ. For the
experiments involving treatment with CHX vs. saline, images
were taken at 20X of an area in the CA1 subfield of the dorsal
hippocampus extending from stratum oriens through stratum
radiatum (2 different sections, 2 images per section in each
animal). All images from a given experiment were taken at
the same exposure and imported into a single Tiff file using
Adobe Photoshop. The tiff image was opened in ImageJ, and
a measuring box was positioned over the CA1 cell body layer.
Mean fluorescence intensity over the cell layer of each individual
image was assessed using the “Measure” function of NIH ImageJ,
and the values were then averaged for each individual animal.
Statistical comparisons were done using Prism Version 6 with
n= number of animals.
Counts of mRNA Puncta in Dendritic Laminae
Counts of mRNA puncta in dendritic laminae were done by
imaging sections using confocal microscopy in order to resolve
individual fluorescent puncta. Image stacks were collected at
63X from stratum radiatum of area CA1 using a Zeiss LSM700
confocal microscope keeping acquisition parameters constant.
The total area of the image was 204.8 µm2. Four image stacks
taken at an interval of 0.55µm (total range of 1.65µm) were
collapsed into a maximum intensity image using the Z project
function. The image was converted to 8-bit, inverted, and
the threshold was adjusted to highlight individual Arc puncta.
Particles were counted using NIH ImageJ “particle analysis.”
To assess fluorescence intensity across the cell body and
molecular layers, 20X images were acquired at the same exposure
and converted to 8-bit gray scale images in ImageJ. Using the
ImageJ line function, a region of interest (ROI) line was defined
as the length of the cell body layer and the dendritic laminae
(250–300µm in length). This ROI was saved and used for each
case and was aligned perpendicular to the cell body layer so
that the middle molecular layer was positioned in the middle
of the line at 150µm for 300µm ROIs and 125µm for 250µm
ROIs, this ensured that despite differences in the widths of cell
body layers, that the region of stimulation (the middle molecular
layer) was aligned across cases. Images from chromogen-based in
situ hybridization acquired in bright field were inverted so that
higher density equated to a greater intensity value. Intensities
were measured across the line every 10µm along the length of
the 20X image (usually about 10 line measurements per image).
Line measurements were averaged across each point in the line to
obtain an average value for each point along the line ROI for each
case. These average line ROI values were averaged across animals
to generate an “average fluorescence intensity (or optical density)
vs. distance” graph with average values± SEM.
Immunohistochemistry (IHC)
For IHC, slide-mounted sections were fixed in 4%
paraformaldehyde, washed, treated with 3% hydrogen peroxide
to block endogenous peroxidase and incubated for 1 h in
at room temperature in 5% Blocking Reagent from Perkin
Elmer (FP1012) before overnight incubation with the primary
antibodies. For Arc, we used an antibody from Synaptic Systems
(156-003, 1:1,000 dilution). EGFP-Arc fusion protein contains
the full length Arc protein, so Arc antibodies detect both
endogenous Arc and EGFP-Arc in transgenic mice. To detect
EGFP, sections were incubated with an antibody to GFP from
Invitrogen (A-11122, 1:1,500).
After incubation in primary antibodies, slides were washed in
TBS, incubated for 2 h with HRP-conjugated donkey anti-rabbit
IgG secondary antibody (Jackson ImmunoResearch, 711-036-
152, 1:500 dilution). HRP was detected using Catalyzed Reporter
Deposition (CARD) amplification as described (Hopman et al.,
1998). In some cases, sections were stained with Hoechst
33258 (1µg/ml) to stain nuclei. Slides were then washed with
TBS, mounted and coverslipped using Vectashield R© (Vector
Laboratories).
SDS-PAGE and Western Blotting
EGFP-Arc tg/tg (N = 5) and WT controls from the breeding
colony (N = 4;10–32 weeks of age) were taken directly from
their home cage and euthanized with Fatal Plus (0.5mL). The left
forebrain (cortex and hippocampus) was rapidly dissected on ice
and homogenized in 250 µL of Lysis Buffer (50mM Tris-HCL,
pH 7.4, 150mM NaCl, 5mM EDTA, 0.05% Triton X-100, 1mM
PMSF, PhosStop phosphatase inhibitor (Roche, cat. 04 906 837
001) and Complete Mini Protease Inhibitor R© (Roche, cat. 04 693
124 001). Homogenates were centrifuged at 15,000× g for 15min
at 4◦C. Protein concentrations were determined with the BioRad
Protein Assay Kit (cat. 500-0006).
For SDS-PAGE, samples were diluted to 1µg/ml in 1X
Laemmli sample buffer, boiled, and 20 µg of protein were loaded
per well and resolved on a 4–20% gradient SDS-PAGE mini-gel
(BioRad, cat. 4561095). Proteins were transferred to Immobilon-
FL polyvinylidene fluoride membranes (PVDF, cat. IPFL00010)
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and blocked with Odyssey Blocking buffer (LI-COR, cat. 927-
40100 PBS blocking buffer); membranes were incubated with
antibodies at a dilution of 1:2,000 rabbit anti-Arc (Synaptic
Systems, cat. 156-003) or 1:10,000 mouse anti-β-actin (Sigma,
cat. A-5441) followed by incubation in goat anti-rabbit IR dye
800CW (LI-COR, cat. 926-32211) or goat anti-mouse 680CW
(LI-COR, cat. 926-68070) at a dilution of 1:15,000. The blots were
scanned using the LI-COR system and imaged using Odyssey
Fc imagining system. Quantification of fluorescent signal band
intensity was done using LI-COR image studio ver.3.1. Values
were normalized to the beta-actin loading control.
Quantitative PCR to Determine Transgene
Copy Number in the Mouse Genome
Genomic DNA was extracted from Proteinase K-digested
liver lysates of wildtype, hemizygous, or homozygous EGFP-
Arc Tg mice. The genomic DNA was then purified through
Phenol/Chloroform extraction and ethanol precipitation, and
analyzed by SYBR green-based qPCR (SYBR Premix Ex Taq II,
Takara Bio, Japan) to determine copy numbers of Arc ORF and
internal control gapdh genes. The primers used are follows:
For ArcORF:
Forward, 5′-AGCTGGACCATATGACCACCGG-3′
Reverse, 5′-CAGGATCACATTGGGTTTGGCG-3′
For gapdh
Forward, 5′-TCTTCACCACCATGGAGAAGGCC-3′
Reverse, 5′-GGCAGAAGGGGCGGAGATGA-3′
The copy number of ArcORF was normalized with that of gapdh
for each genomic DNA sample.
Whole-Genome Sequencing to Identify the
Transgene Integration Site
A DNA library was constructed from genomic DNA of a
homozygous Tg mouse using the TruSeq DNA PCR-Free Library
Prep Kit (Illumina) to perform whole-genome sequencing of
the sample. The library was sequenced on the HiSeq 2500
sequencer (Illumina), yielding 150-bp paired-end reads. The
library adapter sequences at 3′ ends were removed with cutadapt
1.7.1 (Martin, 2011) and low-quality bases (q-score < 16) at
both ends were then trimmed using a custom script. Pairs
containing a read that was shorter than 36 nt were eliminated.
As a result, we obtained 124,547,964 read pairs consisting of
36,875,791,529 bases. The 13.5× FASTQ data weremapped to the
mouse reference sequence GRCm38 or mm10 using the MEM
algorithm of BWA 0.7.12 (Li and Durbin, 2009). We added the
11,829-bp transgenic sequence (i.e., Arc 7k promoter, 5′UTR,
GFP-Arc, and 3′UTR; Kawashima et al., 2009) to the reference
data in advance. If a read was mapped to either the transgene
sequence or the Arc locus (Chr15:74,669,000–74,682,000), the
paired sequences, i.e., along with its counterpart, were extracted
to prepare a BAM file. Using SAMtools 1.2 (Li et al., 2009) and
Integrative Genomics Viewer 2.3.66 (Robinson et al., 2011), we
found many of the counterpart reads were mapped to a region
around Chr12:78,138,000. Then, read pairs in which at least
one of mates was mapped to an 8-kb region, Chr12:78,134,000–
78,142,000, were extracted to prepare another BAM file. Due to
apparent lack of mapped reads, a 1.8-kb homozygous deletion
was easily detected along with 16 informative read pairs that
might span the deletion breakpoints. By aligning these 16 × 2
sequences, two breakpoint sites were determined at single-base
resolution. At both sites, sequences of chromosome 12 and the
EGFP-Arc transgene were connected using 4- and 5-bp shared
fragments, respectively. Other integrations were not detected in
the whole-genome data. Custom programs, which are available
upon request to K.O., were written in Perl and C.
PCR-Based Confirmation of the Transgene
Integration Site
The transgene integration was detected by PCR using tail DNA
with the following specific primers:
Chr12_78MWT primer set 1:
Forward, 5′-AAAGCAATTGTTCACCTGATCTCTGGG-3′
Reverse, 5′-GGTTTCTGTAGGACCTTCACCCACAAG-3′
Chr12_78MWT primer set 2:
Forward, 5′-AGCATCCCTCCAAGGATCATCCCAGTG-3′
Reverse, 5′-TTGGTGGGGGGAGGAAGAGTTCTC-3
Tg junction primer set 1:
Forward, 5′-AAAGCAATTGTTCACCTGATCTCTGGG-3′
Reverse, 5′-CAGGTATCAAGGTGAGTCAGGTCTCCC-3′
Tg junction primer set 2:
Forward, 5′-AGGTTAACCAAGGTCCTACGCCATG-3′
Reverse, 5′-TTGGTGGGGGGAGGAAGAGTTCTC-3
Experimental Design and Statistical Analysis
Comparisons between genotypes were done using mice from the
breeding colony (mostly male mice with a few females as noted
below based on availability at the time of the experiment). Data
were analyzed using Prism Version 6.
Comparisons of levels of Arc mRNA by genotype (Figure 1L)
Brain sections from WT, hemizygous and homozygous EGFP-
Arc mice (n = 3 males per group) were mounted together on
microscope slides and prepared for FISH. Fluorescence intensity
was measured over the pyramidal cell layer of CA1. Data were
analyzed by one-way ANOVA.
Quantitative PCR to determine transgene copy number in
different genotypes (Figure 2B)
Four WT, 4 hemizygous and 8 homozygous mice were used
for PCR. Data were analyzed by one-way ANOVA comparing
groups.
Assessment of mRNA rundown after actinomycin-D infusion
in vivo (Figure 2D)
The ratio of fluorescence intensity over the granule cell layer of
the dentate gyrus in the area of actinomycin-D infusion vs. the
contralateral side of the same section was determined in WT vs.
homozygous EGFP-Arc mice (n = 4 of each genotype without
ACT-D infusion, n = 2 WT female mice and 4 EGFP-Arc male
mice at 30min and n= 3 male mice of each genotype at 60min).
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Data were analyzed by two-way ANOVA comparing groups vs.
time post-ACT-D.
Counts of fluorescent puncta in dendritic laminae after ECS
(Figure 3E)
Fluorescent puncta were quantified in the molecular layer
following ECS in WT vs. EGFP-Arc transgenic mice (n = 3 mice
per group) at 3 locations (outer, middle, and inner molecular
layer). Data were analyzed by two-way ANOVA comparing
groups and layers.
Quantification of mRNA levels in home cage controls vs. after
exploration of a novel environment (Figure 4E)
Groups were: (1) WT-home cage saline, n = 2 males; (2) WT-EE
saline: n = 5 males; (3) EGFP-Arc-home cage, n = 4 males; (4)
EGFP-Arc-EE n = 5 males. Data on fluorescence intensity over
the CA1 pyramidal cell layer were analyzed separately for WT
and EGFP-Arc by t-test.
Quantification of Western blot (Figure 5H)
Samples from EGFP-Arc tg/tg (n = 4 females and 1 male) and
WT controls (n = 3 females and 1 male) were run on the same
Western blot and fluorescence signal intensity in Arc and Arc-
GFP bands was normalized to the beta actin loading control. Data
were analyzed by one-way ANOVA.
Neurophysiology (Figures 6, 7)
As noted in the Results, localization of Arc at activated synapses
in the ECS-ECStim paradigm, which is highly reliable in
rats, occurs less reliably in mice. Accordingly, data on Arc
mRNA distribution across the molecular layer are quantified for
individual mice, but are not analyzed statistically.
Quantification of mRNA levels in home cage controls vs. after
1 h exploration of a novel environment with and without
CHX treatment (Figures 8M,N)
Groups were: (1) WT-home cage saline, n = 2 males; (2) WT-
home cage CHX, n = 4 males, (3) WT-EE saline: n = 5 males;
(4) WT-EE CHX: n = 3 males, 2 females; (5) EGFP-Arc-home
cage saline, n = 4 males; (6) EGFP-Arc-home cage CHX, n = 4
males; (7) EGFP-Arc-EE saline n = 5 males; (8) EGFP-Arc-EE
CHX n = 5 males. Data on fluorescence intensity over the
CA1 pyramidal cell layer were analyzed by two-way ANOVA
comparing treatment (saline vs. CHX) and experience (home
cage vs. EE). Data from saline-treated control mice are from
Figure 4.
RESULTS
Total Arc mRNA (EGFP-Arc + Endogenous
Arc mRNA) Is Overexpressed in EGFP-Arc
Transgenic Mice
Arc is expressed as an immediate early gene (IEG); under
resting conditions, mRNA levels are low or non-detectable
in most neurons in the cortex and hippocampus, whereas
transcription is strongly induced by learning experiences or
other events that cause strong synaptic activation. Although
Arc is expressed in neurons throughout the forebrain, we focus
here on patterns of Arc expression in the hippocampus and
dentate gyrus because these illustrate general rules regarding
regulation of Arc expression. Figure 1A illustrates fluorescence
in situ hybridization (FISH) for Arc mRNA in a WT mouse
that was one of the “saline controls” for the study described
below involving injections of cycloheximide (CHX); as such, this
mouse received an intra-peritoneal (IP) injection of saline and
was returned to its home cage for 1 h before being anesthetized.
Arc mRNA is detectable in some neurons in the CA1 region of
the hippocampus and a few dentate granule cells express Arc at
moderate levels. As will be seen below, this extent of expression
is somewhat higher than seen in mice that were anesthetized
immediately upon removal from their home cage without prior
saline injections, reflecting some activation as a result of the
handling and IP injection 1 h prior to euthanasia.
To assess whether expression of EGFP-Arc is expressed in
a similar way as endogenous Arc, we used hemizygous mice
with one allele of EGFP-Arc transgene, and assessed transgene
expression using cRNA probes specific for EGFP-Arc mRNA.
As illustrated in Figure 1B, the overall pattern of expression in
the hippocampus was comparable to endogenous Arc mRNA. If
EGFP-Arc mRNA is not subject to the same decay mechanisms
as endogenous Arc mRNA, then overall levels of labeling for
EGFP-Arc should be higher than for endogenousArc inWTmice.
Consistent with this prediction, when sections from hemizygous
mice were also hybridized using the probe for endogenous Arc,
which recognizes both Arc and EGFP-Arc mRNAs because the
full-length coding sequence of Arc is present in the transgene,
levels of labeling were much higher than for endogenous Arc in
WT mice (Figure 1C). It is important to note that the images in
Figures 1A,C are from sections from WT and hemizygous mice
that were processed together in the same in situ hybridization run
using the same cRNA probe.
Comparisons of levels of Arc mRNA in WT, hemizygous
and homozygous EGFP-Arc mice revealed that levels of labeling
for Arc mRNA were higher in homozygous EGFP-Arc than
in hemizygous, and both were higher than WT. This can be
appreciated by comparing levels of labeling in the CA1 region
in WT (Figure 1D), hemizygous (Figure 1E), and homozygous
EGFP-Arc mice (Figure 1F). Differences in labeling by genotype
were confirmed by measuring fluorescence intensity over
the CA1 region in 3 mice per genotype (Figure 1L). One-
way ANOVA, revealed overall significance [F(2, 6) = 19.83,
p = 0.0023] and pairwise post-hoc comparisons by the Holm-
Sidak multiple comparisons test indicated significant differences
between all 3 genotypes (for details on statistics, see figure
legend). Although elevated levels of EGFP/Arc mRNA are
consistent with impaired mRNA decay, it is important to note
that overall Arc transcription is also elevated due to the presence
of both native and EGFP-Arc and the fact that there are multiple
copies of the transgene (see below).
We note here that there is little detectable labeling for EGFP-
Arc mRNA in dendritic lamina in CA1 despite high levels of
labeling over pyramidal cell bodies. We initially suspected that
this might be due to the fact that dendritic labeling is most
prominent afterArc is induced by some stimulus. As documented
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FIGURE 1 | Patterns of expression of endogenous Arc vs. EGFP-Arc mRNAs. (A) Fluorescence in situ hybridization (FISH) for Arc mRNA in a WT mouse that received
I.P. saline and was returned to its home cage for 1 h. HC-SC = home cage, saline control. Arc mRNA is detectable in some neurons in the CA1 region of the
hippocampus and a few dentate granule cells express Arc at moderate levels. (B) Hemizygous EGFP-Arc mouse (home cage saline control) hybridized with the EGFP
probe; (C) Hemizygous EGFP-Arc mouse (home cage saline control) hybridized with the Arc probe; (D–F) Higher magnification views of the CA1 region from WT,
hemizygous and homozygous transgenic mice. (G) Hilar region of the dentate gyrus from hemizygous EGFP-Arc mouse (home cage saline control) hybridized with the
EGFP probe. Arrows indicate fluorescent foci in nuclei; (H) Hilar region of the dentate gyrus from hemizygous EGFP-Arc mouse (home cage saline control) hybridized
with the Arc probe; (I) Hilar region of the dentate gyrus from homozygous EGFP-Arc mouse (home cage saline control) hybridized with the Arc probe; (J) High
magnification view of a neuron in the hilar region from homozygous EGFP-Arc mouse (home cage saline control) hybridized with the Arc probe. Note two large and
two small fluorescent foci in the nucleus. (K) Same neuron viewed by confocal microscopy with DAPI shown in blue fluorescence. (L) Quantification of fluorescence
intensity over CA1 region in mice of different genotypes hybridized with the Arc probe. One-way ANOVA [F (2, 6) = 19.83, p = 0.0023]; pairwise comparisons by
Holm-Sidak multiple comparisons test: WT vs. Hemi, t = 3.7, p < 0.05; WT vs. Homo, t = 6.3, p < 0.01; Hemi vs. Homo, t = 2.6, p < 0.05 Calibration bar in
(A) = 500µm and applies to (A–C). Calibration bar in (D) = 100µm and applies to (D–F). Scale bar in (I) = 50µm and applies to (G–I).
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below, however, there is little detectable dendritic labeling for
EGFP-Arc mRNA when Arc is massively induced in dentate
granule cells by ECS.
Visualization of EGFP-Arc mRNA
Transcription Foci
With fluorescence in situ hybridization, mRNAs appear as
discrete fluorescent puncta, and active transcription foci appear
as distinct spots in neuronal nuclei. For example, transcription
foci are evident in neurons in the CA1 region in the image from
WT mice in Figure 1D. We noticed that when using a probe
specific for EGFP-Arc in hemizygous EGFP-Arcmice, there were
single distinct fluorescent foci in the nuclei of many neurons
(Figure 1G). This is a higher magnification view of the hilar
region of the dentate gyrus in the section shown in Figure 1B.
We interpret these foci as transcription sites for EGFP-Arc, and
simple face validation of this interpretation is that two foci are
evident in nuclei of neurons in sections from tg/tg mice that
were hybridized with the probe for EGFP-Arc (not shown, but
see next). Interestingly, when sections from hemizygous EGFP-
Arc mice were hybridized with the probe for endogenous Arc,
which recognizes both EGFP-Arc and endogenous Arc, single
fluorescent foci were evident in the nucleus of many neurons
(Figure 1H; each arrow points to a neuron with a single focus).
In contrast, 2 foci were evident in the nuclei of homozygous
EGFP-Arc mice hybridized with the probe for endogenous Arc
(Figure 1I; each arrow points to a neuron with two foci).
The fact that there is one large labeled focus in nuclei per
allele of the transgene suggests higher levels of labeling of the
EGFP-Arc transcription site vs. the two transcription sites for
WT Arc. Support for this interpretation comes from the fact
that in homozygous transgenic mice, neurons could be seen with
two large and two small fluorescent nuclear foci. This can be
seen with regular fluorescence microscopy (Figure 1J), but is
even more evident by confocal microscopy (Figure 1K). Because
the number of large foci varies by genotype, it is highly likely
that the two large foci are transcription foci for EGFP-ArcmRNA
and the two small foci are transcription foci for WT Arc mRNA.
Four spatially-separate loci are consistent with the fact that
whole-genome sequencing in the transgenic line used in this
study revealed that the endogenous Arc gene and EGFP-Arc
transgene are on different chromosomes; the endogenous Arc
gene is present on Chr 15 while the EGFP-Arc transgene is
integrated at Chr 12. The exact integration site of the transgene
was identified at Chr12:78,137,441 and 78,139,250, resulting in a
deletion of 1,808 bp. Analyses with UCSC-Genome Browser and
PCR revealed that there are no disrupted genes by the integration
of transgene at this site (Figure 2A).
One possible explanation for the higher levels of labeling
at EGFP-Arc transcription sites is that multiple copies of the
transgene integrate in tandem into the locus. To assess this, we
used quantitative PCR to estimate copy number (see section
Methods), which revealed that that there are approximately 15
copies of the transgene per locus [Figure 2B, One-way ANOVA
F(2, 13) = 233.7, p < 0.0001]. Thus, the higher levels of labeling at
the EGFP-Arc transcription foci is most likely due to integration
of multiple copies of the transgene. Other contributions cannot
be excluded, including: (1) EGFP-Arc may be transcribed at a
higher level than endogenous Arc in the same individual nucleus
driven by its own 7 kb Arc promoter. (2) EGFP-Arc pre-mRNA
does not contain the introns present in endogenous Arc pre-
mRNA, and thus may be retained at transcription foci for longer
than endogenousArc that undergoes splicing. (3) The presence of
the coding sequence of EGFP in tandemwith the coding sequence
of Arc may interfere with intra-nuclear processing, causing the
EGFP-Arc transcript to be retained near the transcription site.
Whatever the explanation, the large foci provide a convenient
and reliable means to genotype mice by in situ hybridization.
EGFP-Arc mRNA Is Degraded More Slowly
than Endogenous Arc mRNA
To determine the time course of degradation of EGFP-ArcmRNA
vs. endogenousArcmRNA, we assessed rundown ofmRNA levels
after transcriptional block with Act-D. Arc transcription was
induced in homozygous transgenic and WT mice by delivering
an electroconvulsive seizure (ECS), mice were prepared for
in vivo neurophysiology and a recording micropipette containing
Act-D was stereotaxically positioned in the dentate gyrus at
approximately 1 h post-ECS. After 30 and 60min, brains were
harvested for FISH.
After a single ECS, Arc transcription is strongly induced in
dentate granule cells and transcriptional activation persists for
hours. This is evidenced by continued high levels of labeling
for Arc mRNA in dentate granule cells. In WT mice, local
infusion of Act-D led to progressive decreases in Arc mRNA
levels in an area about 300–500µm in diameter surrounding the
micropipette (Figure 2C; area of blockade is between the arrows).
To quantify the time course of mRNA decay, we analyzed Arc
mRNA fluorescence intensity in the region of Act-D infusion and
in the surrounding regions of the dentate gyrus and expressed
this as a ratio (2 mice at 30min and 3 mice at 60min). At each
time point, Arc mRNA levels decreased to about half of the
level 30min prior (Figure 2D). This is consistent with previous
determinations of the time course of ArcmRNA decay after Act-
D treatment of neurons in culture, which indicate a half life for
ArcmRNA of about 45min (Rao et al., 2006).
When the same experiment was done with homozygous
EGFP-Arc mice and sections were hybridized for EGFP mRNA,
it was difficult to locate an area of diminished labeling due to
Act-D. To define the area of transcriptional blockade, sections
from EGFP-Arc mice were hybridized with a probe specific for
the intron in endogenous Arc mRNA. As expected, the area
of transcriptional blockade was revealed by absence of labeling
for the intron probe in an area surrounding the Act-D filled
micropipette (Figure 2E). Based on this identification of the
region of transcriptional blockade, we hybridized nearby sections
(usually adjacent sections) for EGFP mRNA (Figure 2F), and
quantified levels of labeling in the area of transcriptional blockade
vs. nearby regions (4 mice at 30min; 3 mice at 60min). This
analysis confirmed delayed rundown of EGFP-Arc mRNA levels
with Act-D (Figure 2D, two-way ANOVA Group difference
[F(1, 14) = 5.289, p = 0.0374], effect of time [F(1, 14) = 14.12,
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FIGURE 2 | Transgene characterization and assessment of degradation of Arc vs. EGFP-Arc mRNA following infusion of Act-D into the dentate gyrus. (A) Schematic
diagram illustrating the genomic integration site of the EGFP-Arc transgene at Chromosome 12 of the mouse genome. The most upper panel represents a 550 kb
region of mouse Chr12 around the integration site (78,137,4411–78,139,250), showing that the insertion point is 87.4 kb upstream of the nearest gene, Gephyrin
(Gphn: 78,226,655–78,684,769). Representative agarose gel patterns at the bottom show PCR-based confirmation of the transgene integration. Locations of the
primers are shown in the schematic genomic structures in the middle. (B) Quantification of the copy number of the transgene. The copy numbers of Arc ORF
sequences were estimated in WT, hemizygous, and homozygous mice using qPCR. In (C–F) Arc transcription was induced by ECS and about 45min post ECS,
Act-D was infused via micropipette positioned in the dentate gyrus. (C) Arc mRNA levels in wildtype (WT) mice 1 h post-Act-D as revealed by FISH; Act-D injection site
is between the white arrows. (D) Quantitative assessment of decreases in mRNA levels over time in WT and EGFP-Arc transgenic mice. Bars illustrate average
fluorescence intensity in the area of the injection as a percent of surrounding areas outside the region of blockade (n = 3 mice per time point except for 30min WT and
60min EGFP-Arc where n = 2). (E) Pattern of labeling for Arc mRNA intron probe in EGFP-Arc mouse 1 h. post-Act-D. Note absence of labeling in the area of the
Act-D injection site between the white arrows. (F) Near-adjacent section from the same mouse shown in (C) hybridized with the probe for GFP. Note preservation of
labeling in the area between the white arrows indicating abrogation of EGFP-Arc mRNA decay. Scale bar = 100µm.
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p = 0.0004]; by 60min, levels of labeling for EGFP-Arc mRNA
remained about 75% of the levels at sites outside the area of
blockade.
Impaired Dendritic Delivery of EGFP-Arc
mRNA after Induction by Seizures
In our assessment of Arc vs. EGFP-Arc mRNA levels after ECS,
it was again evident that levels of labeling in dendrites appeared
lower for EGFP-Arc mRNA than for endogenous Arc mRNA
(compare Figure 3A: Arc WT with Figure 3B: EGFP-Arc). To
assess this, sections were imaged by confocal microscopy in
order to resolve individual fluorescent puncta in the dendritic
laminae of the dentate gyrus (Figures 3C,D). We then counted
the number of puncta in the inner, middle, and outer molecular
layer (IML, MML, and OML, respectively n = 3 mice per group
at 90–120min post ECS). Quantitative analyses confirmed that
despite strong induction of transcription, there were far fewer
dendritic EGFP-Arc mRNA puncta than Arc mRNA puncta
in WT mice [Figure 3E, 2-way ANOVA, difference between
groups: F(1, 4) = 119.9, p = 0.0004, difference between layers:
F(2, 8) = 130.7, p < 0.0001]. These results indicate impaired
dendritic delivery of EGFP-ArcmRNA to distal dendritic regions,
even when ArcmRNA transcription is strongly induced.
One possible explanation for impaired dendritic delivery
is impaired nucleocytoplasmic transport of newly-synthesized
EGFP-Arc mRNA. To explore this possibility, we used confocal
microscopy to image fluorescence from FISH and nuclei of
dentate granule cells stained with DAPI to assess whether newly-
synthesized EGFP-Arc mRNA entered the cytoplasm. Confocal
images in inWTmice revealed high levels of cytoplasmic labeling
for Arc mRNA consistent with efficient nucleocytoplasmic
transport (Figure 3F). In transgenic mice, EGFP-ArcmRNA was
also clearly present in cytoplasm (Figure 3G). It is noteworthy
that Arc mRNA in WT mice is present in discrete granules
whereas EGFP-Arc mRNA appears in globs, inviting the
speculation that theremay be a deficiency in packaging EGFP-Arc
mRNA into granules or in granule trafficking.
EGFP-Arc Transcription Is Regulated by
Experience in a Manner Similar to
Endogenous Arc
Arc mRNA transcription is induced by learning experiences,
and a simple paradigm to demonstrate this is to allow
animals to explore a novel toy-filled enriched environment
(EE), which in WT mice is accompanied by robust induction
of Arc transcription (Farris et al., 2014). Figure 4A illustrates
fluorescence in situ hybridization for ArcmRNA in a WT mouse
that was anesthetized immediately after being removed from its
home cage and Figure 4B illustrates the labeling for Arc in a WT
mouse that was allowed to explore a novel environment for 1 h.
As previously described in rats (Farris et al., 2014), this learning
experience led to increases in ArcmRNA levels in neurons in the
CA1 region of the hippocampus, and increases in the number
of Arc-positive dentate granule cells. For quantitative analyses,
fluorescence levels were quantified over the pyramidal cell layer
of CA1 as in Figure 1L (Figure 4E). Endogenous Arc mRNA
FIGURE 3 | Deficient/delayed dendritic transport of EGFP-Arc mRNA after
induction by ECS. (A) Arc mRNA distribution as revealed by FISH following
ECS. Note punctate labeling in the dendritic lamina. IML, MML, and OML
indicate inner, middle and outer molecular layer, respectively. (B) EGFP-Arc
mRNA distribution in the same case as revealed by FISH for GFP mRNA. Note
the absence of punctate labeling in the dendritic lamina. (C) Collapsed
confocal stacks illustrating individual Arc mRNA fluorescent puncta from FISH
preparations in the middle molecular layer (dendritic laminae of the dentate
gyrus). (D) Confocal stacks of EGFP-Arc mRNA. (E) Counts of Arc and
EGFP-Arc mRNA puncta from the inner, middle, and outer molecular layer
(IML, MML, and OML, respectively N = 3 mice per group at 90–120min post
ECS). Asterisks indicate p < 0.0004. (F) Confocal stack illustrating Arc mRNA
fluorescence in granule cell bodies of WT mice; nuclei are stained with
DAPI-stained nuclei. (G) Confocal stack illustrating EGFP-Arc mRNA
fluorescence in granule cell bodies of transgenic mice. Scale bar in (A)
=50µm and applies to (A,B). Scale bar in (G) = 25µm and applies to (H,G).
levels were about 3-fold higher after 1 h of exploration (n= 2HC,
5EE, t= 3.169, p= 0.0248). EGFP-ArcmRNAwas expressed with
similar dynamics; Figure 4C illustrates the pattern of expression
of EGFP-Arc mRNA in a home cage control hemizygous mouse
and Figure 4D illustrates striking increases in EGFP-Arc mRNA
levels in a hemizygous mouse that was allowed to explore a novel
environment for 1 h. In Figures 4C,D, EGFP-Arc mRNA was
detected using FITC, which provides a convenient color code for
illustrating EGFP-Arc vs. Arc mRNAs. Levels of fluorescence for
EGFP-Arc mRNA as assessed by hybridization using the probe
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FIGURE 4 | Induction of Arc and EGFP-Arc mRNAs by exploration of a novel
environment. (A) Fluorescence in situ hybridization (FISH) for Arc mRNA in a
WT mouse that was anesthetized immediately after being removed from its
home cage (WT HC). (B) FISH labeling for Arc mRNA in a WT mouse that was
allowed to explore a novel enriched environment for 1 h (WT EE). (C) FISH for
EGFP-Arc mRNA (FITC detection) in an EGFP-Arc hemizygous mouse that
was anesthetized immediately after being removed from its home cage
(Transgenic HC). (D) FISH for EGFP-Arc mRNA (FITC detection) in an
EGFP-Arc hemizygous mouse that was allowed to explore a novel enriched
environment for 1 h (Transgenic EE). (E) Quantification of Arc and EGFP-Arc
mRNAs as a result of experience. Sections from all mice were hybridized at the
same time for either Arc or GFP mRNA, and levels of fluorescence over the
pyramidal cell layer of CA1 were quantified (as in Figure 1L). Scale bar in
(B) = 250µm.
for GFP was elevated to about the same extent as endogenous Arc
mRNA (n= 4HC, 5EE, t = 15.78, p < 0.0001).
It should be noted that the “home cage controls” illustrated
in Figure 4A were transported in their home cage from the
vivarium to the testing room along with the mice that were
exposed to the novel environment, which included transport in
an elevator, and then the mice were euthanized. Probably because
of this experience, levels of labeling are higher over the pyramidal
cell layers and there are more Arc-positive granule cells in the
mouse illustrated in Figure 4A than in the mouse illustrated
in Figure 1A, which was euthanized immediately after removal
from its home cage in the vivarium.
Total Arc Protein Levels (Endogenous Arc
+ EGFP-Arc) Are Elevated in Transgenic
Mice and Increase Further as a Result of a
Learning Experience
To assess whether differences in levels of expression of Arc and
EGFP-Arc mRNAs were paralleled by differences in the levels
of the respective proteins, sections were immunostained using
antibodies against Arc. InWTmice, immunofluorescence for Arc
protein in home cage controls revealed patterns of expression
that were similar to what has been described in previous studies
(Figure 5A). Levels of labeling were low over the cell body
laminae of the hippocampus. Most dentate granule cells were
unstained, but there were a few labeled granule cells scattered
through the granule cell layer, especially in the dorsal blade. As
noted above, EGFP-Arc protein contains the full Arc sequence,
so antibodies against Arc also recognize EGFP-Arc protein, so
immunofluorescence indicates expression of total Arc protein
(endogenous Arc + EGFP-Arc). As with the mRNAs, levels of
expression of Arc and EGFP-Arc proteins were much higher
under basal (home cage) conditions in EGFP-Arc transgenic
mice (Figure 5B). Especially noteworthy was the high level of
immunofluorescence throughout the dendritic laminae of CA1
and prominent staining of dendrites of dentate granule cells.
In WT mice, 1 h of exploration in an enriched environment
led to robust increases in Arc immunofluorescence in
hippocampal subfields, especially in CA1, and increases in
the number of Arc-positive granule cells (Compare Figure 5C
with Figure 5A). There was also strong induction of expression
of total Arc protein (endogenous Arc+ EGFP-Arc) in transgenic
mice (Compare Figure 5D with Figure 5B). It was noteworthy
that by the end of the 1 h in the enriched environment, total
Arc protein levels increased in both cell bodies and throughout
dendrites. This was especially evident in CA1, where increases in
immunofluorescence were seen even in the zone containing the
most distal dendrites of CA1 pyramidal cells (stratum oriens and
stratum lacunosum-moleculare).
Sections from the same transgenic mice were also
immunostained using the antibody for GFP so as to detect the
level and distribution of EGFP-Arc protein only. Overall, patterns
of labeling for EGFP mirrored the patterns for total Arc protein;
especially noteworthy was that levels of immunofluorescence for
GFP were high over the dendritic laminae of the hippocampus
under resting conditions (Figure 5E) and increased further after
1 h in the enriched environment (Figure 5F).
In order to estimate the extent to which total Arc protein was
elevated in EGFP-Arc transgenic mice, cortical tissue from WT
(n = 4) and homozygous transgenic (n = 5) mice was prepared
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FIGURE 5 | Induction of expression of Arc and EGFP-Arc mRNAs by exploration of a novel environment is accompanied by increased expression of Arc and
EGFP-Arc proteins. (A) Immunofluorescence for Arc protein in a WT mouse that was anesthetized immediately after being removed from its home cage (Arc-IF
WT-HC). (B) Immunofluorescence for Arc protein in an EGFP-Arc transgenic mouse that was that was anesthetized immediately after being removed from its home
cage (Arc-IF EGFP-HC). Note higher levels of labeling for Arc protein in the EGFP-Arc transgenic mouse (Arc-IF EGFP-HC). (C) Immunofluorescence for Arc protein in
a WT mouse that was allowed to explore a novel enriched environment for 1 h (Arc-IF WT-EE). Note substantial induction Arc protein expression.
(D) Immunofluorescence for Arc protein in an EGFP-Arc transgenic mouse that was allowed to explore a novel enriched environment for 1 h (Arc-IF EGFP-EE).
(E) Immunofluorescence for GFP in an EGFP transgenic mouse that was that was anesthetized immediately after being removed from its home cage (GFP-IF-HC).
(F) Immunofluorescence for GFP in an EGFP-Arc transgenic mouse that was allowed to explore a novel enriched environment for 1 h (GFP-IF-EE). (G) Western Blot
analysis of Arc protein in WT (n = 4 mice) and EGFP-Arc transgenic mice (n = 5). Green fluorescence: Arc protein ß-actin: red fluorescence. E-ARC: band of
fluorescence for EGFP-Arc in the transgenic. N-Arc: band of fluorescence for endogenous Arc protein. (H) Quantification of the levels of fluorescence in the N-Arc and
E-Arc bands (two-way ANOVA, p < 0.0001). Scale bar in (E) = 250µm.
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for Western Blot analysis using an antibody against Arc (green
fluorescence in Figure 5G) and an antibody against ß-actin as
a loading control (red fluorescence). A band of fluorescence for
endogenous Arc protein (N-Arc) is evident at around 50 kDa and
a band of fluorescence for EGFP-Arc is evident at approximately
90 kDa in the transgenic mice, consistent with the predicted
MW of the EGFP-Arc fusion protein (EGFP 32.7 kDa + Arc 55
kDa = 87.7 kDa). Quantification of the levels of fluorescence
in the bands revealed that average levels of endogenous Arc
were comparable in WT vs. EGFP-Arc +/+ mice, whereas levels
of fluorescence for EGFP-Arc were about 7.6-fold higher than
endogenous Arc. Thus, total Arc (endogenous + EGFP-Arc
protein) is about 9-fold higher in the transgenic mice (two way
ANOVA, p < 0.0001).
High basal levels of EGFP-Arc expression could reflect
enhanced transcription, but this could occlude activity-
dependent transcriptional activation; however, levels of
EGFP-ArcmRNA were robustly elevated as a result of experience
in the novel environment. The fact that transcription of EGFP-
Arc mRNA in transgenic mice can be activated in a manner
similar to endogenous Arc indicates that transcriptional activity
is not saturated. Moreover, as we show below, EGFP-Arc protein
is also not degraded as quickly as endogenous Arc, contributing
to the net overexpression in the transgenic mice.
Assessing Activity- and Protein
Synthesis-Dependence of Arc mRNA
Degradation
We previously characterized activity- and protein synthesis-
dependent Arc mRNA degradation in physiological experiments
in rats (Farris et al., 2014). For this, we used the ECS-Perforant
Path stimulation paradigm in which Arc is induced by an
electroconvulsive seizure (ECS) and time is allowed for the
mRNA to move throughout dendrites (1 h). In the absence of
synaptic stimulation, Arc mRNA levels are high throughout
the dendritic lamina (molecular layer) of the dentate gyrus.
Following high frequency synaptic stimulation (HFS) of the
perforant path, Arc mRNA localizes selectively in the activated
dendritic lamina (Steward and Worley, 2001) and is depleted
from non-activated portions of the dendrite due to activity-
driven protein synthesis-dependent mRNA degradation (Farris
et al., 2014).
Figures 6A–C illustrate these phenomena in WT mice using
chromogen-based in situ hybridization. Following ECS, Arc
mRNA is delivered throughout dendrites (Figure 6A). Perforant
path stimulation then produced a distinct laminar pattern of
labeling with higher levels of labeling in the zone of termination
of the medial perforant path and lower levels of labeling
in the outer molecular layer; arrows in Figure 6B indicate a
distinct boundary between the two zones. Figure 6C illustrates
a quantitative analysis of optical density (OD) across the granule
cell layer and molecular layer with ECS only vs. ECS/PPStim.
A similar laminar pattern of labeling could be seen when
WT mice were subjected to the ECS/PPStim paradigm and Arc
mRNA levels were assessed by FISH. For example, Figure 6E
illustrates the pattern of labeling for Arc mRNA in a WT mouse
after ECS and 1 h of PPStim. However, the phenomenon was not
seen as reliably in mice as in previous studies involving rats. For
example, a distinct laminar pattern such as shown in Figure 6E
was evident in 8/12 experiments inWTmice, whereas we observe
striking lamination in every experiment in rats. This may be
due to differences in the physiology of perforant path synapses
in mice. For example, perforant path LTP itself is less reliable
in mice than in rats (Steward et al., 2007). Also, although Arc
mRNA transcription is strongly induced by ECS in WT mice,
high frequency stimulation (HFS) of the perforant path alone
typically does not strongly activate Arc transcription in large
numbers of dentate granule cells (Steward et al., 2007).
In our previous study (Farris et al., 2014) the ECS-Perforant
Path stimulation paradigm provided strong evidence for activity-
and translation-dependent Arc mRNA degradation. If this
degradation depends on splicing, it should not occur for EGFP-
Arc mRNA. We tested this in a total of 7 EGFP-Arc mice that
received ECS followed by HFS of the perforant path. When
sections from EGFP-Arc mice were hybridized for Arc mRNA,
ArcmRNAwas present in a gradient in dendrites on the ECS only
side (Figure 6G) and the laminar pattern of labeling was seen
in some mice (Figure 6H), although quantitative assessments
revealed that the effect was modest (Figure 6I). In contrast,
hybridization with the probe for EGFP mRNA revealed intense
labeling in cell bodies but very little labeling in the dendritic
lamina on either the ECS only side (Figure 6J) or ECS-PPStim
side (Figure 6K; and for quantification, see Figure 6L). Thus, the
impairment of dendritic delivery of EGFP-Arc mRNA seen with
ECS alone is also evident with ECS-PPStim. Because EGFP-Arc
mRNA does not traffic out to dendrites in the time frame of the
experiment, no inference can be drawn from the ECS-PPStim
experiment in the Arc-EGFP+/+mice about whether EGFP-Arc
mRNA in dendrites is subject to activity-driven decay.
Translation-Dependence of Arc mRNA
Degradation
In our previous study in rats, we showed that activity-driven
Arc mRNA degradation is abrogated in the presence of protein
synthesis inhibitors, consistent with an NMD-like process (Farris
et al., 2014). The first test was to locally-infuse cycloheximide
(CHX) via a recording microelectrode during the stimulation
phase of the ECS/PPStim paradigm. As predicted by the
hypothesis that Arc mRNA degradation is via NMD, Arc mRNA
levels were increased in the area of protein synthesis blockade.
Although the largest percent increase was in the activated
dendritic lamina, increases were also seen in the cell body lamina,
so this experiment is not compromised by the fact that delivery of
EGFP-Arc mRNA is impaired.
We used the same paradigm in mice and found similar results
for endogenous Arc mRNA. Figures 7A,C illustrate Arc mRNA
levels in the area of CHX infusion in a WT mouse; Figures 7B,D
illustrate the contralateral side of the same section (ECS only);
and Figures 7F,G illustrate Arc mRNA levels on the stimulated
side in areas distant from the CHX infusion. The graphs in
Figures 7E,H plot fluorescence intensity across the cell body
and molecular layers. As previously documented in rats (Farris
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FIGURE 6 | Assessment of localization of Arc and EGFP-Arc mRNA at active synapses: ECS-Perforant Path stimulation paradigm (termed ECS/PPStim). Mice
received a single ECS to induce Arc time is allowed for the mRNA to move throughout dendrites (1 h), then high frequency stimulation (HFS) is delivered to the
perforant path, which causes newly-synthesized Arc mRNA to localize selectively in the activated dendritic lamina (Steward and Worley, 2001). Accumulation of Arc
mRNA in the activated dendritic lamina is accompanied by disappearance from non-activated portions of the dendrite leading to a selective band of labeling in the
activated lamina. (A) Chromogen-based ISH for Arc mRNA after ECS; WT C57Bl/6 mouse. (B) Distinctive laminar pattern of labeling on the side that received
perforant path stimulation. Arrows indicate the distinctive boundary between the activated lamina and the outer molecular layer. (C) Quantification of optical density
(OD) across the granule cell layer (GCL) and dendritic laminae. The red arrow indicates the higher level of labeling in the activated zone; the black arrow indicates the
outer molecular layer where levels of labeling are decreased on the stimulated side. (D) FISH for Arc mRNA after ECS in WT mouse. (E) Distinctive laminar pattern of
labeling on the side that received perforant path stimulation. Arrows indicate the boundary between the activated lamina and the outer molecular layer.
(F) Quantification of fluorescence intensity across the granule cell layer (GCL) and dendritic laminae. (G) Arc mRNA distribution in a tg/tg transgenic mouse after ECS
as revealed by FISH for Arc mRNA. (H) Arc mRNA distribution on the side that received perforant path stimulation (PPStim). (I) Quantification of fluorescence intensity
across the granule cell layer and dendritic laminae from panels (G,H). (J,K) EGFP-Arc mRNA distribution in the same EGFP-Arc transgenic mouse after ECS as
revealed by FISH for GFP mRNA. (L) Quantification of fluorescence intensity across the granule cell layer and dendritic laminae from panels (J,K). Scale bar in
(D) = 250µm and applies to (A,B,D,E). Scale bar in (K) = 50µm and applies to (G,H,J,K).
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FIGURE 7 | Local infusion of CHX leads to increases in Arc mRNA levels in the area of protein synthesis blockade, consistent with translation-dependent mRNA
decay. Mice received a single ECS to induce Arc and 1 h later were prepared for neurophysiology with a recording micropipette filled with CHX. Then high frequency
stimulation (HFS) was delivered to the perforant path. (A) Arc mRNA distribution as revealed by FISH in the area of CHX infusion with perforant path stimulation
(PPStim). Arrow indicates path of CHX-containing micropipette. (B) Arc mRNA distribution on the contralateral side (ECS only). White boxes indicate the areas
illustrated in (C,D). (C,D) Higher magnification views of Arc mRNA distribution across the cell layer and dendritic layers in the area of CHX infusion and on the
contralateral side of the same section. (E) Graph of fluorescence intensity across the cell layers and dendritic layers from images in (C,D). Red arrow indicates the
band of Arc mRNA in the activated dendritic lamina. (F,G) Arc mRNA distribution across the cell layer and dendritic layers in a section distant from area of CHX
infusion and on the contralateral side of the same section. (H) Graph of fluorescence intensity across the cell layers and dendritic layers from images in (F,G). (I,J)
illustrate the distribution of Arc mRNA and GFP mRNA, respectively from an experiment in which mice received a single ECS to induce Arc and were prepared for
neurophysiology immediately with a recording micropipette filled with CHX. Then high frequency stimulation (HFS) was delivered to the perforant path. Note
accumulation of Arc mRNA in the activated lamina in (I) and the absence of GFP mRNA in dendrites in (J). (K) Graph of fluorescence intensity across the cell layers
and dendritic layers from images in (I,J). Scale bar in (A) = 250µm and applies to (A,B). Scale bar in (F) = 50µm and applies to (C,D), (F,G), and (I,J).
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et al., 2014) Arc mRNA levels were elevated in the area of CHX
blockade that extends for a diameter of about 1mm around the
infusion site, especially in the activated dendritic lamina. Note
that labeling is decreased in an area about 150µm in diameter
at the center of the infusion due to damage produced by the
micropipette.
To test whether EGFP-Arc mRNA levels would also increase
with CHX blockade, we carried out the same experiment as above
in EGFP-Arc transgenic mice with one variation; rather than
waiting 1 h after ECS before preparing mice for neurophysiology,
we induced ECS and then immediately prepared mice for
neurophysiology placing the CHX-filled micropipette as soon as
possible. The time from ECS to placement of the CHX-filled
micropipette was about 15min. Then we delivered HFS to the
perforant path for 1 h. The rationale was to prevent translation
of newly-transcribed Arc mRNA, which would prevent any
translation dependent degradation. As illustrated in Figure 7I,
hybridization with the probe for Arc mRNA revealed dendritic
labeling with localization in the activated lamina (Figure 7I).
However, hybridization of nearby sections with the probe for
GFP mRNA revealed induction of expression due to ECS, but
no labeling in the dendritic lamina (Figure 7J). It’s important
to reiterate that the probe for Arc mRNA recognizes both
endogenous Arc and EGFP-Arc mRNAs. Because EGFP-Arc
mRNA did not move into dendrites (Figure 7J) the labeling in
the dendritic lamina with probes for Arc mRNA must reflect
endogenous ArcmRNA.
The fact that dendritic delivery of EGFP-Arc mRNA is
impaired even when translation of newly-transcribed mRNA is
blocked (Figure 7J) is strong evidence against the possibility that
dendritic delivery is impeded because of translation of the EGFP-
Arc fusion protein per se. This points to the interpretation that
deficient delivery is related to the fact that EGFP-Arc mRNA is
not spliced and thus would not retain EJC proteins that otherwise
might facilitate the shuttling of an EGFP-ArcmRNA complex out
of the nucleus into the cytoplasm. A much less likely possibility
that we cannot fully exclude is that dendritic delivery is impeded
because of some sequestration signal in the GFP coding sequence
that causes the mRNA to be largely retained in the cell body, thus
over-riding the dendritic transport signal(s) that would otherwise
mediate dendritic delivery of endogenous ArcmRNA.
Inhibition of Protein Synthesis in
Awake-Behaving Mice Does Not Lead to
Increases in Arc mRNA Levels
The second way we tested protein synthesis-dependence of Arc
mRNA in Farris et al. (2014) was to block protein synthesis
during a learning experience (1 h exploration of a novel toy-filled
environment). As predicted by translation-dependent decay, Arc
mRNA levels were higher in rats treated with CHX in both
the home cage and EE condition. Increases were qualitatively
evident over both cell body and dendritic laminae of the
hippocampus.
Here, we used the same basic approach in WT and EGFP-Arc
transgenic mice. Mice were gently removed from their home cage
and received injections of either CHX or saline, and were then
either immediately returned to their home cage for 1 h, or were
allowed to explore a novel environment for 1 h.
To our surprise, and in striking contrast to what we
documented in rats, CHX did not lead to increased Arc mRNA
levels in WT mice in either the home cage or after exploration of
the novel environment (EE in figure panels).ArcmRNA levels are
not noticeably higher in the mouse that received CHX (Compare
Figure 8A, control, with Figure 8B, CHX); this is confirmed
by quantitative analysis of fluorescence intensity over the CA1
pyramidal layer (Figure 8M; values for saline-treated HC and EE
mice are the same as shown in Figure 1L. Values for individuals
are shown along with bar graphs to indicate numbers of animals
per condition). Although Arc mRNA levels were induced in WT
mice that explored the novel environment [two-way ANOVA for
home cage vs. EE: F(1, 10) = 31.76, p = 0.0002], there were no
differences between mice that received saline vs. CHX [two-way
ANOVA: F(1, 10) = 0.064, p= 0.805]. ArcmRNA levels were also
comparable with and without CHX in the home cage (HC) group
(Figure 8M). Similar results were seen in homozygous EGFP-Arc
transgenic mice [Figure 8N, two-way ANOVA for home cage vs.
EE: F(1, 14) = 166.3, p < 0.0001], with no differences between
saline vs. CHX groups [two-way ANOVA: F(1, 14) = 1.333,
p= 0.2676].
In our previous study (Farris et al., 2014), differences in
Arc mRNA levels were qualitatively evident over both cell body
and dendritic laminae but the quantitative analyses assessed the
number of ArcmRNA puncta in the dendritic layer. Accordingly,
we wondered whether we were missing an effect by measuring
fluorescence intensity over the cell body lamina. Thus, we
analyzed the number of Arc mRNA puncta per unit area of
stratum radiatum in WT-EE mice using confocal stacks as in
Figure 3. Again, there were the expected differences in Arc
mRNA puncta between HC and EE groups, but no differences
with and without CHX. Puncta counts were: WT-HC saline-
535 ± 91, WT-HC CHX-587 ± 31, WT-EE saline-1559 ± 515,
WT-EE CHX-1490± 693.
Given the absence of an effect of CHX in WT mice, it is not
surprising that blockade of protein synthesis also did not lead
to increases in EGFP-Arc mRNA levels in homozygous EGFP-
Arc transgenic mice that were allowed to explore the enriched
environment. Figures 8C,D illustrate levels of EGFP-Arc mRNA
following hybridization with probes for GFP (see Figure 8N
for quantification). EGFP-Arc mRNA levels were somewhat
elevated in homozygous EGFP-Arc transgenic mice that received
CHX and were returned to their home cage (Figure 8N), but
differences were not statistically significant (t = 2.71, df = 6,
p= 0.412).
Persistence of EGFP-Arc Protein Following
CHX-Treatment
In WT mice, blockade of protein synthesis with CHX prevents
the increases in Arc protein that are otherwise seen with
exploration of an enriched environment and also leads to loss
of immunostaining, so that the Arc-positive dentate granule
cells that are normally present are no longer evident (Compare
Figure 8E, saline with Figure 8F, CHX-treated). This run-down
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FIGURE 8 | Systemic delivery of CHX does not lead to increases in Arc mRNA in awake behaving mice. WT and Transgenic mice were allowed to explore a novel
enriched environment with and without CHX treatment to inhibit protein synthesis. (A) Fluorescence in situ hybridization (FISH) for Arc mRNA in a WT mouse that
received saline (WT EE). (B) Fluorescence in situ hybridization (FISH) for Arc mRNA in a WT mouse that received CHX (WT EE+CHX). (C) Fluorescence in situ
hybridization (FISH) for Arc mRNA for EGFP-Arc mRNA (FITC detection) in a tg/tg transgenic mouse that received saline (Transgenic EE). (D) Fluorescence in situ
(Continued)
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FIGURE 8 | hybridization (FISH) for Arc mRNA (FITC detection) in a tg/tg transgenic mouse that received CHX (Transgenic EE+CHX). (E,F) Immunofluorescence for
Arc protein in the WT mice illustrated in (A,B). Note absence of Arc IF in the WT mouse treated with CHX (F). (G,H) Immunofluorescence for Arc protein in the tg/tg
transgenic mice illustrated in (C,D). Note persistence of Arc IF in the EGFP-Arc transgenic mouse treated with CHX (H). (I,J) Higher magnification views of Arc positive
granule cells in the dentate gyrus from the sections shown in (G,H). Note some decrease in immunofluorescence of dendrites in (J). (K,L) Immunofluorescence for
c-Fos protein in the transgenic mice illustrated in (G,H) to confirm rundown of c-Fos protein in transgenic mice after CHX treatment. (M) Quantification of fluorescence
intensity for Arc mRNA over CA1 for the different groups of WT mice. (N) Quantification of fluorescence intensity for Arc mRNA over CA1 for the different groups of
tg/tg transgenic mice. EGFP-Arc mRNA levels were somewhat elevated in transgenic mice that received CHX vs. saline and were returned to their home cage, but
differences were not statistically significant (t = 2.71, df = 6, p = 0.412). (O,P) Higher magnification views of c-Fos positive granule cells in the dentate gyrus from the
sections shown in (G,H). Scale bar in (D) = 250µm and applies to (A–L). Scale bar in (J) = 100µm and applies to (I,J). Scale bar in P = 25µm and applies to (O,P).
of Arc protein is a convenient way to confirm the effectiveness
of CHX treatment. Surprisingly, EGFP-Arc protein did not run
down with CHX treatment in the same way as endogenous
Arc. In EGFP-Arc transgenic mice, although CHX treatment did
block the increases in immunostaining that otherwise occur after
exploration of a novel environment, this did not lead to the
complete disappearance of Arc-positive neurons as in wildtype
mice (compare Figure 8G with Figure 8H and Figure 8I with
Figure 8J). It was noteworthy in the high magnification views
in Figures 8I,J that CHX did block the increases in Arc protein
in the dendrites of dentate granule cells. This suggests that
the appearance of EGFP-Arc protein in dendrites occurs with
kinetics similar to that of endogenous Arc protein in the
wildtype mice. The relative absence of EGFP-Arc mRNA means
that this occurs via a mechanism other than local protein
synthesis.
To exclude the possibility that protein degradation
machineries were overwhelmed by induced overexpression
of EGFP-Arc proteins, we tested whether CHX caused a
rundown of other IEG proteins in EGFP-Arc transgenic mice.
For this, sections adjacent to those taken from the mice shown
in Figures 8G,H were immunostained for c-Fos (Figures 8K,L).
There were the expected number of c-Fos positive granule cells
in the mouse that received saline before exploration of the
novel environment (Figure 8K; higher power views of dentate
granule cells are shown in Figure 8O), and only a few c-Fos
labeled granule cells were present in the mouse that received
CHX (Figures 8L,P). Thus, degradation of endogenous Arc and
c-Fos proteins was intact and unaffected 1 h following CHX-
treatment whereas EGFP-Arc protein persisted, at least within
the cell bodies of the dentate gyrus granule cells. The apparent
persistence of EGFP-Arc protein may reflect a quantitative
difference (near 8-fold overexpression), a qualitative difference
(delayed turnover due to slower local decay kinetics), or both.
One possible explanation for the latter is that the presence of
EGFP in the EGFP-Arc recombinant protein alters degradation
kinetics.
DISCUSSION
The original goal of this study was to test the hypothesis that
activity- and translation-dependent degradation of Arc mRNA
occurs via NMD, which depends on the presence of EJC protein
binding in the 3′UTR. The approach used transgenic mice
carrying an EGFP-Arc transgene constructed from Arc cDNA,
which lacks two introns in the 3′UTR that are present in
the endogenous Arc gene. The canonical signal for NMD is
an EJC downstream of a stop codon, so EGFP-Arc mRNA
should not be susceptible to NMD. Our findings were consistent
with the NMD hypothesis: (1) EGFP-Arc mRNA decayed
more slowly following transcriptional blockade than endogenous
Arc mRNA indicating impaired mRNA degradation; (2) Local
infusion of CHX in the ECS/PPStim paradigm led to increases
in endogenous Arc mRNA in the area of protein synthesis
blockade, consistent with translation-dependent Arc mRNA
degradation.
Our results also revealed an unexpected and striking
impairment of dendritic delivery of EGFP-Arc mRNA. This
suggests the intriguing possibility that the presence of an intact
splice junction and accompanying EJC proteins might provide an
additional activity-regulated mechanism to enhance delivery of
ArcmRNA into dendrites. In what follows, we discuss the caveats
of the experiments and un-expected findings that provide new
insights into ArcmRNA dynamics.
Role of Nonsense Mediated Decay (NMD)
in Arc mRNA Turnover
Previous studies have documented that ArcmRNA is a canonical
candidate for NMD because of the presence of splice junction
sites in the 3′UTR downstream of the stop codon (Giorgi et al.,
2007). Proteins of the exon junction complex (EJC) remain
bound to Arc mRNA as it moves into the cytoplasm and
EJC’s downstream of a stop codon are the canonical signal for
triggering NMD when a translating ribosome reaches the stop
codon. In support of the NMD hypothesis, our previous studies
in rats (Farris et al., 2014) showed that Arc mRNA degradation
is attenuated by protein synthesis inhibitors and accelerated by
synaptic stimulation.
The EGFP-Arc transgene was created by inserting a
monomeric EGFP cDNA into mouse Arc cDNA with its 5′
and 3′ UTRs under the control of the Arc7000 promoter
(pGL4.11-Arc7000-mEGFP-Arc-UTRs). Arc cDNA lacks the
introns in the 3′UTR so the transcript never undergoes splicing.
If Arc mRNA turnover is via an NMD-like mechanism, then:
(1) EGFP-Arc mRNA should be degraded more slowly than
endogenous Arc mRNA; (2) Inhibition of protein synthesis
should not lead to increases in EGFP-Arc mRNA levels seen
with endogenous Arc mRNA (Farris et al., 2014). Our results
confirmed the first prediction; assessment of rundown of induced
Arc mRNA levels after blockade with the transcription inhibitor
actinomycin-D revealed that EGFP-ArcmRNA is degraded more
slowly than endogenous ArcmRNA.
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The test of the second prediction was compromised for
two reasons. First, local infusion of CHX in the ECS/PPStim
paradigm did lead to increases in endogenous Arc mRNA in
the activated dendritic lamina; however, EGFP-Arc mRNA did
not enter dendrites even in the presence of CHX, so it was
not possible to asses for increases in dendrites due to protein
synthesis inhibition. Second, inhibition of protein synthesis with
CHX in awake behaving mice did not lead to increases in
endogenous Arc mRNA, so this test of translation-dependence
was not relevant in mice. It is unknown why Arc mRNA turnover
in mice is less translation-dependent than is the case in rats.
Although the tests of the hypothesis yielded results that were
more complicated than expected, the evidence does support the
hypothesis thatArcmRNA decay is either regulated by splicing of
the 3′UTR (perhaps by EJC proteins that accompany ArcmRNA
into the cytoplasm) or that insertion of the coding sequence for
EGFP disrupts some signal in the coding region that regulates
mRNA decay. Thus, a mechanism with NMD-like characteristics
contributes to Arc mRNA degradation, and this mechanism is
disrupted in EGFP-Arc transgenic mice, disrupting normal IEG
dynamics.
Although our results indicate that the presence of introns
plays a role in regulating mRNA decay, EGFP-Arc mRNA is
degraded, albeit with a slower time course, indicating that
mechanisms other than NMD also contribute. In this regard,
it is noteworthy that a recent study reports that the presence
of the 3′UTR sequence called the “dendritic targeting element
(DTE)” in fusion transcripts also confers destabilizing activity
independent of NMD (Ninomiya et al., 2016).
Impaired Dendritic Delivery of
Newly-Synthesized EGFP-Arc mRNA
An unexpected discovery was the striking difference in the
delivery of endogenous Arc mRNA vs. EGFP-Arc mRNA into
dendrites even after massive induction by ECS. This suggests
a deficiency in steps leading to dendritic transport of newly-
synthesized EGFP-Arc mRNA. Dendritic transport of many
mRNAs is thought to depend on sequences in the 3′UTR, but
after splicing of endogenous Arc mRNA, the sequence of the
UTR would be identical to that of EGFP-ArcmRNA; thus, 3′UTR
sequence alone is not sufficient to mediate efficient dendritic
transport of EGFP-Arc mRNA. Possible explanations include:
(1) Rapid dendritic delivery after induction may depend on one
or more EJC proteins that are retained with endogenous Arc
mRNA after 3′UTR splicing; (2) Efficient dendritic delivery may
be disrupted by the presence of the sequence for EGFP in the
coding region.
The fact that EGFP-ArcmRNA is not delivered into dendrites
even when translation of newly-transcribed EGFP-Arc mRNA is
blocked (Figure 7J) argues against the possibility that dendritic
delivery is impeded because of translation of the EGFP-Arc
fusion protein. It is also unlikely that dendritic delivery is
impeded because the EGFP coding sequence contains some
signal that causes the mRNA to be retained in the cell body
because EGFP was previously used with success as a reporter
for characterizing the dendritic targeting sequence in the
fully spliced 3′UTR of Arc mRNA (Kobayashi et al., 2005).
Thus, the most likely interpretation is that impaired delivery
is related to the fact that EGFP-Arc mRNA is not spliced
and thus would not retain EJC proteins. It is noteworthy
that localization of oskar mRNA in the posterior pole of the
Drosophila oocyte also depends on splicing and presumably
deposition of EJC proteins upstream of the exon-exon junction
(Hachet and Ephrussi, 2004). The authors propose that splicing
is important for regulating ribonucleoprotein complex assembly
and organization for cytoplasmic localization. In this regard, the
fact that EGFP-Arc mRNA is present in globs in the perinuclear
cytoplasm rather than discrete puncta is consistent with the idea
that splicing plays a role in packaging the RNA into granules
or in granule trafficking thereafter. It may be that splicing and
deposition of EJC proteins is a more general mechanism that is
critical for mRNA localization in both developing systems and
mature neurons.
Our previous studies using live cell imaging document that
fusion transcripts with the Arc 3′UTR and MS2 binding sites
are transported in dendrites (Dynes and Steward, 2008) and
localize with a high degree of precision at the base of dendritic
spines (Dynes and Steward, 2012). The DNA constructs for these
fusion transcripts were also made from Arc cDNA, and so would
not undergo splicing. Thus, splicing and/or the presence of EJC
proteins at the splice site are not absolutely required for dendritic
transport of transcripts containing the Arc 3′UTR or selective
localization at spines.
Selective Localization of
Newly-Synthesized Arc mRNA at Active
Synapses
Arc mRNA localizes selectively in dendritic domains contacted
by active synapses (Steward et al., 1998), due mainly to selective
accumulation of newly-synthesized Arc mRNA (Farris et al.,
2014). However, there was no hint of accumulation of newly-
synthesized EGFP-Arc mRNA in the activated dendritic lamina
in any of the transgenic mice tested. Thus, signals induced
by strong synaptic activation that enhance dendritic delivery
of endogenous Arc mRNA are not sufficient to overcome the
impaired dendritic transport of newly-synthesized EGFP-Arc
mRNA.
Levels of EGFP-Arc Protein Are High
throughout Dendrites Despite Low Levels
of EGFP-Arc mRNA
It is often assumed that high levels of Arc protein in
dendrites depend on the presence and local translation of
Arc mRNA. Despite impaired dendritic delivery of EGFP-Arc
mRNA, however, EGFP-Arc protein levels were very high in
the dendrites of some neuron types under resting conditions,
particularly neurons in the CA1 region of the hippocampus
(Figure 5E). EGFP-Arc protein does not run down as quickly
after protein synthesis inhibition as endogenous Arc, so high
levels of expression of EGFP/Arc protein may be due to a
combination of delayed degradation of EGFP-Arc mRNA and
delayed degradation of EGFP-Arc protein.
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It is noteworthy that increases in EGFP-Arc protein levels
with ECS- or repetitive PP stimulation were mainly in the cell
body and proximal dendritic regions (for example, Figure 5F).
These results suggest two independent, yet not mutually exclusive
possibilities: (1) In hippocampal neurons that express EGFP-
Arc at high levels under resting conditions, EGFP-Arc protein
can reach the distal tips of dendrites even with only a small
contribution of local translation of dendritically delivered EGFP-
Arc mRNA. (2) However, activity-dependent increases with
seizures, synaptic stimulation or learning occur mainly in
subcellular domains in which EGFP-Arc mRNA is localized.
This may be because such activity regimes favor local protein
translation.
Implications for Previous Studies Involving
EGFP-Arc Transgenic Mice
The EGFP-Arc transgenic mice used here express an EGFP-Arc
fusion protein, and thus differ from other Arc-GFP reporter
transgenic mouse lines. In one other line, the coding region
of Arc is entirely replaced with a GFP gene, thus causing an
Arc knockout (Wang et al., 2006). In another series of mouse
lines, destabilized GFP was driven by an Arc promoter in a
bacterial artificial chromosome (BAC) (Grinevich et al., 2009)
or as a transgene (Eguchi and Yamaguchi, 2009; Vousden et al.,
2015), with variable amounts of activity-dependent inducibility
and background expression. These lines have subsequently been
used to identify neurons in which Arc expression has been
induced, e.g., Jakkamsetti et al. (2013) but the reporter is not
an Arc-GFP fusion protein and thus would not be germane to
elucidating the role of different sequences in affecting dendritic
transport. In contrast, the Arc transgenic line used here has both
copies of the endogenous Arc gene as well as multiple copies
of the EGFP-Arc transgene, and over-expresses total Arc mRNA
and protein (endogenous Arc + EGFP-Arc). Accordingly, the
EGFP-Arc tg/tg transgenic mice will be useful models for studies
of the physiological and behavioral consequences of Arc over-
expression coupled with alterations in dendritic transport. In
this regard, a recent study has reported that one type of ocular
dominance plasticity persists in adult mice from anmCherry-Arc
Tg line with approximately 8-fold overexpression of Arc in
comparison to WT (Jenks et al., 2017).
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